Kite Pharma, Inc. Conversion of Stock, Amount Issued
Kite Pharma, Inc. reported Conversion of Stock, Amount Issued of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountIssued1 · last filed 2017-02-28
- Kite Pharma, Inc. conversion of stock, amount issued for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- Kite Pharma, Inc. conversion of stock, amount issued for the quarter ending 2014-09-30 was $0.00.
- Kite Pharma, Inc. conversion of stock, amount issued for the quarter ending 2013-12-31 was $2.39M.
- Kite Pharma, Inc. conversion of stock, amount issued for the quarter ending 2013-09-30 was -$2.39M.
- Kite Pharma, Inc. conversion of stock, amount issued for fiscal 2016 was $0.00.
- Kite Pharma, Inc. conversion of stock, amount issued for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- Kite Pharma, Inc. conversion of stock, amount issued for fiscal 2014 was $2.52M, a 4.61% decline from fiscal 2013.
- Kite Pharma, Inc. conversion of stock, amount issued for fiscal 2013 was $2.65M.
| Period end | Conversion of Stock, Amount Issued 3 month | Conversion of Stock, Amount Issued 6 month | Conversion of Stock, Amount Issued 9 month | Conversion of Stock, Amount Issued 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $2.52M 10-K · filed 2017-02-28 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $2.52M 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $2.52M 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $2.65M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $254.00K 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $2.65M 10-Q · filed 2014-08-14 |